PharmaEngine

NCT02901483

Phase 1/2, Terminated, 2016, 12 people, 15 Sept 2016, clinicaltrials.gov

NCT02379845

Collaborator, Phase 2/3, Completed, 2015, 180 people, 5 Mar 2015, clinicaltrials.gov